WHO has sounded the alarm about the rise in Monkeypox cases in Europe and elsewhere.

Since the first case of monkeypox was confirmed in London on May 7 (the patient was a traveler from Nigeria, where monkeypox has recently been endemic), more and more countries have reported cases in the following days and weeks, which is "atypical" for monkeypox.

Monkeypox is an infection caused by the monkeypox virus, which used to be predominantly endemic in West and Central Africa.

Confirmed and suspected cases of monkeypox are now present in several Western countries, including the United Kingdom, Portugal, Spain, Italy, Sweden, the United States, Canada, and Australia...

Map: Where has monkeypox been detected so far?

Source: Infographic News - WiredPRNews.com

The World Health Organization (WHO) said that as of May 26, 269 confirmed cases and 74 suspected cases of monkeypox had been reported in 21 countries worldwide. Meanwhile, WHO has expanded surveillance in non-endemic countries and will guide countries on monkeypox prevention in the coming days.

Source: BNO News

Diagnosis of Monkeypox Virus——

Clinical identification of monkeypox is the first step in the diagnosis. Confirmation of the diagnosis of monkeypox in the current domestic and international market requires a series of laboratory tests; among these tests are：

1) Polymerase chain reaction (PCR) analysis.

2) cell culture isolation of the virus.

3) Enzyme-linked immunosorbent assay (ELISA).

4) Antigen detection test.

It is essential to note that antigen and antibody tests do not provide monkeypox-specific confirmation due to the cross-reactive nature of monkeypox virus serology. Therefore, serological and antigenic assays are not recommended for diagnostic or case investigation in resource-limited areas. PCR and cell culture isolation of virus indicate virus presence in the sample to be tested. Given their accuracy and sensitivity, the samples for PCR monkeypox are vesicles, pustular fluid, crusts, and blood specimens, with the best diagnostic samples coming from the tops or fluids of vesicles and pustules of skin lesions and dried crusts.

Getein Monkeypox Virus Real-time PCR Test Solution ——

Step 1：Disposable Virus Sampling Tube

The first step of the Getein monkeypox virus solution is sample extraction, starting with the Disposable Virus Sampling Tube. This tube collects, transports, and stores human nasopharyngeal virus and rash fluid samples. The disposable virus sampling tube contains guanidine salt, which can inactivate the virus and keep the virus nucleic acid stable. The sample preservation solution has a stable transportation and storage environment.

Step 2：Nucleic Acid Extraction Kit

The second step of this solution is to extract and purify viral nucleic acids (DNA and RNA) in samples.

This kit consists of unique separation function magnetic beads and a unique buffer system. The magnetic beads release the adsorbed nucleic acid when the conditions change, which can rapidly separate and purify nucleic acid. The whole process is safe and convenient. This kit has pure and stable quality, suitable for the automatic extraction of high-throughput workstations.

Step 3：Monkeypox Virus Real-time PCR Kit

Getein Monkeypox Virus Real-time PCR Kit is designed for MPV (FAM marker) with a highly conserved sequence as target regions. This technology also can monitor sample sampling, nucleic acid extraction, and detection to avoid false-negative results.

After rigorous testing, the solution has the technical features of rapid detection, accuracy and safety, multiple monitoring, and high sensitivity. The coefficient of variation (CV%) of the precision within-run is no more than 5%.

Lyophilized Type

 Non-Lyophilized Type

Getein has closely monitored the international public health situation since the outbreak of the monkeypox epidemic. Getein will play its role in the monkeypox epidemic and every possible global public health issue in the future by exerting its influence as a leading Chinese IVD company and carrying forward its corporate social responsibility.